|
Volumn 5, Issue 20, 2006, Pages
|
The clinical investigation of Securigera securidaca (L.) (Degen & Doerfler) seeds in type II diabetic patients; a randomized, double-blind, placebo-controlled study
|
Author keywords
Clinical study; Diabetes; Herbal medicine; Securigera securidaca
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ALKALINE PHOSPHATASE;
ASPARTATE AMINOTRANSFERASE;
CHOLESTEROL;
CREATININE;
GLUCOSE;
HEMOGLOBIN A1C;
HERBACEOUS AGENT;
HIGH DENSITY LIPOPROTEIN;
LOW DENSITY LIPOPROTEIN;
PLACEBO;
PLANT EXTRACT;
TRIACYLGLYCEROL;
AMINOTRANSFERASE BLOOD LEVEL;
ARTICLE;
CHOLESTEROL BLOOD LEVEL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CREATININE BLOOD LEVEL;
DRUG EFFICACY;
DRUG SAFETY;
FOLLOW UP;
GLUCOSE BLOOD LEVEL;
HUMAN;
LIPID BLOOD LEVEL;
MAJOR CLINICAL STUDY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PHASE 2 CLINICAL TRIAL;
PLANT SEED;
RANDOMIZED CONTROLLED TRIAL;
SECURIDACA;
SECURIGERA SECURIDACA;
UNSPECIFIED SIDE EFFECT;
UREA NITROGEN BLOOD LEVEL;
CORONILLA SECURIDACA;
|
EID: 34249936961
PISSN: 2717204X
EISSN: 27172058
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (16)
|
References (8)
|